PWP
EXAS

Perfromance Wealth Partners’s Exact Sciences EXAS Stock Holding History

Perfromance Wealth Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,737
Closed -$350K – 175
2023
Q4 		$350K Sell
4,737
-565
-11% -$37K 0.02% 119
2023
Q3 		$362K Hold
5,302
– – 0.02% 126
2023
Q2 		$499K Sell
5,302
-463
-8% -$36.1K 0.02% 118
2023
Q1 		$391K Buy
+5,765
New +$371K 0.02% 129

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Perfromance Wealth Partners's EXAS Position: Q1 2024 in Review

Perfromance Wealth Partners sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 4,737 shares — an estimated $350K sold.

Perfromance Wealth Partners first reported a position in EXAS in Q1 2023 and held it in 4 quarters. The position peaked at $499K in Q2 2023. 626 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Perfromance Wealth Partners reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Perfromance Wealth Partners sold 4,737 Exact Sciences shares in Q1 2024, an estimated $350K.
  • Perfromance Wealth Partners first reported a position in Exact Sciences in Q1 2023 and held it in 4 quarters.
  • Perfromance Wealth Partners's Exact Sciences position peaked at $499K in Q2 2023.
  • 626 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Perfromance Wealth Partners's 13F filing for Q1 2024, filed 30 Apr 2024.